Anti-Human Endoglin (hCD105) Immunotoxin—Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1
Endoglin (CD105) is an accessory component of the TGF-β receptor complex, which is expressed in a number of tissues and over-expressed in the endothelial cells of tumor neovasculature. Targeting endoglin with immunotoxins containing type 2 ribosome-inactivating proteins has proved an effective tool...
Main Authors: | Begoña Barriuso, Pilar Antolín, F. Javier Arias, Alessandra Girotti, Pilar Jiménez, Manuel Cordoba-Diaz, Damián Cordoba-Diaz, Tomás Girbés |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-06-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/8/6/184 |
Similar Items
-
Serum Level of a Soluble Form of Endoglin (CD105) is Decreased after Goeckerman’s Therapy of Psoriasis
by: David Pohl, et al.
Published: (2011-01-01) -
CD105/ENDOGLIN EXPRESSION IN A MOUSE MODEL OF ACUTE MUSCLE CONTUSION
by: Antoanela Curici, et al.
Published: (2014-12-01) -
Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
by: Ana Nogués, et al.
Published: (2020-05-01) -
Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy
by: Pilar Jiménez, et al.
Published: (2011-04-01) -
Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
by: Virginia Di Paolo, et al.
Published: (2018-01-01)